DNBS/Ethanol administration in the vehicle group increased several pathways, including amino acid uptake, carbohydrate synthesis, lipid uptake, and mucin overproduction metabolism while denosumab treatment reduced such pathways in DNBS/Ethanol colitis mice. This evidence concerns the gene MUC5AC and colitis.